In this segment we will be talking to Supreme Pharmaceuticals’ (OTC: SPRWF) (CSE: SL) CEO, Mr. David Stadnyk, as well as licensed attorney and Head of Operations, Mr. John Fowler.
Supreme Pharmaceuticals Inc. (OTC: SPRWF) (CSE: SL) is an aspiring licensed producer under Canada's Marihuana for Medical Purposes Regulations ("MMPR"). In June, the company closed on its acquisition of a Southern Ontario based firm that holds a pre-build MMPR license that's pending a final security audit by Health Canada.
With 342,000 square feet of grow space capable of producing up to 24,000 kilograms per year, the recent acquisition could make SPRWF one of the largest producers in Canada once successful in obtaining licensed producer status.
Supreme Pharmaceuticals is Headquartered in Vancouver and is a publicly traded company listed in the US under ticker symbol SPRWF and in Canada under the symbol SL.
Investors are encouraged to visit the companies website at supremepharmaceuticals.com.
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?